Treatment Information


Lung Cancer treatment details. Chemotherapy, Radiation, Surgery.

Washington University Medical Center, St. Louis, MO, United States.

Survival: monthsCountry:United States
Toxiciy Grade:5City/State/Province:St. Louis, MO
Treatments:Chemotherapy, Radiation, SurgeryHospital:Washington University Medical Center
Date:May 2005


Patients: This Phase II study involved 88 patients diagnosed with non-small-cell lung cancer (resected stage II or IIIA) Fifty-seven patients were men, and thirty-one were women. Forty-nine patients (56%) were younger than 60 years old.

Treatment: The treatment involved surgery and thoracic radiotherapy and chemotherapy with two drugs: paclitaxel and carboplatin.

Toxicity: There was one septic death. Grade 3-4 toxicities included granulocytopenia, leukopenia, thrombocytopenia, esophagitis, respiratory, and neurologic toxicity.

Results: The median overall survival was 56.3 months.

Support: Some authors have served as consultants, advisors or grant recipients to various pharmaceutical companies.

Correspondence: Jeffrey D. Bradley, M.D.